Lexicon Pharmaceuticals (LXRX) Goodwill & Intangibles (2010 - 2026)

Lexicon Pharmaceuticals (LXRX) has reported Goodwill & Intangibles for 17 consecutive years, with $44.5 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Goodwill & Intangibles changed 0.0% year-over-year to $44.5 million; the TTM figure through Mar 2026 stood at $44.5 million (changed 0.0% YoY), while the FY2025 annual figure was $44.5 million, changed 0.0% from the prior year.
• Goodwill & Intangibles steadied at $44.5 million in Q1 2026 per LXRX's latest filing, from $44.5 million in the prior quarter.
• Across five years, Goodwill & Intangibles topped out at $44.5 million in Q1 2022 and bottomed at $44.5 million in Q1 2022.
• Historically, Goodwill & Intangibles has averaged $44.5 million across 5 years, with a median of $44.5 million in 2022.
• On a YoY basis, Goodwill & Intangibles climbed as much as 0.0% in 2022 and fell as far as 0.0% in 2022.
• Lexicon Pharmaceuticals' Goodwill & Intangibles stood at $44.5 million in 2022, then changed by 0.0% to $44.5 million in 2023, then changed by 0.0% to $44.5 million in 2024, then changed by 0.0% to $44.5 million in 2025, then changed by 0.0% to $44.5 million in 2026.
• Business Quant data shows LXRX's Goodwill & Intangibles at $44.5 million in Q1 2026, $44.5 million in Q4 2025, and $44.5 million in Q3 2025.